Evidence map›Paper›PMID 42193926›Full record

ArticleCells2026

Detection of Calpain-Mediated Beclin-1 Cleavage for Drug Discovery in Inflammatory Bowel Diseases.

Kylee A Hunter, Anne-Marie C Overstreet, Bryon Benjamin Koff, Hridai Dharan, Steven Overend, Jeannette S Messer

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kylee A HunterDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
Anne-Marie C OverstreetDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0009-0008-6701-1640
Bryon Benjamin KoffDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
Hridai DharanDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.
Steven OverendDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.ORCID 0009-0007-3171-9244
Jeannette S MesserDepartment of Microbial Sciences in Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44195, USA.

Funding

NIH HHS 1K08DK111471-23NIH HHS 1R01HL178625-25The American Gastroenterological Association AGA Microbiome Junior Investigator Research AwardThe Gastrointestinal Research Foundation NA
6 · The paper itself

Abstract

Inflammatory bowel diseases (IBDs) are diseases of chronic inflammation and intestinal epithelial cell (IEC) death that affect an estimated 7 million people worldwide. Intestinal barrier restoration is the most important determinant of remission in IBD, yet there are very few existing therapies that protect IECs from damage or support epithelial repair. The goal of this study was to develop a model system and tools that can be used to identify therapeutics that promote IEC survival in IBD. We developed a Beclin-1 cleavage reporter (BICR) that detects calpain-mediated Beclin-1 cleavage and the switch from autophagy to programmed cell death. We modified BICR with the HIV Tat peptide (BICR-Tat) and tested it in a model of live bacterial stress using commensal

Indexed as

Beclin-1CalpainDrug DiscoveryInflammatory Bowel DiseasesAnimalsAutophagyEpithelial CellsEscherichia coliHumansIntestinal Barrier FunctionIntestinal MucosaBeclin-1Calpainautophagybacteriabarrier healingcalpaininflammatory bowel diseaseintestinal epithelial cellprogrammed cell death

Identifiers

PMID42193926
PMCPMC13204207

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.